Organon (OGN) Insider Cynthia Patton Buys $240K of Stock
Cynthia Patton added 17,857 shares of Organon & Co. on June 12, 2026, joining several colleagues in a wave of open-market purchases.
Reviewed by automated data checks against the source filing. How we make and check alerts
Cynthia Patton bought 17,857 shares of Organon & Co. ($OGN) at an average price of $13.44, worth about $239,998.08, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $OGN is down 0.3% after 1 week, up 0.5% after 1 month and up 2.5% to date (from the $13.42 close on Jun 12, 2026).
OGN
Organon & Co.
Key Points
- Cynthia Patton purchased 17,857 shares of Organon & Co. (NYSE:OGN) on June 12, 2026, at a price of $13.44 each for a total value of $239,998.08.
- The transaction formed part of a coordinated round of open-market purchases on the same day by multiple leaders, including Robert Essner, Alan Ezekowitz, Helene Gayle, Rochelle Lazarus, and Deborah Leone, who all acquired identical blocks of 17,857 shares.
- Organon & Co. stock trades near its 52-week high of $13.79, supported by a trailing P/E ratio of 17.5 and a forward P/E of 3.8.
Get $OGN trade alerts by text
We text you when insiders, Congress or big funds trade $OGN. Free.
Not investment advice. TradeTexts is not a registered investment adviser, and this automated Organon & Co. alert may contain errors. Disclosures
Cynthia Patton Adds to Organon & Co. Stake
Cynthia Patton stepped in to acquire 17,857 shares of Organon & Co. (NYSE:OGN) on June 12, 2026. The shares were picked up at a price of $13.44 apiece, bringing the total cost of the transaction to $239,998.08. This open-market purchase brings fresh attention to the healthcare firm's leadership team as shares trade near upper valuation levels.
A Coordinated Wave of Insider Purchases
The transaction did not happen in isolation. On June 12, 2026, several other figures made identical moves across the leadership group. Robert Essner purchased 17,857 shares at $13.44 each for a total of $239,998.08. Alan Ezekowitz acquired the exact same block of 17,857 shares at the same price point. Helene Gayle also picked up 17,857 shares valued at $239,998.08. Rochelle Lazarus joined the group by grabbing 17,857 shares on that date. Finally, Deborah Leone rounded out the wave by purchasing 17,857 shares for $239,998.08.
Organon & Co. Stock Price Context
Organon shares trade at $13.44, sitting close to the 52-week high of $13.79 and far above the 52-week low of $5.69. The stock rests comfortably above both its 50-day moving average of $13.64 and its 200-day moving average of $10.59. The company has a market capitalization of roughly $3.59 billion, a trailing P/E ratio of 17.5, and a forward P/E ratio of 3.8.
Inside Organon & Co.'s Business
Organon & Co. focuses on women's health solutions and other prescription therapies across global markets. The Jersey City, New Jersey-based firm provides contraception and fertility brands, biosimilars, and various medications addressing cardiovascular, respiratory, and dermatological conditions. Founded in 1923, the company supplies hospitals, pharmacies, and clinics worldwide.
What to Watch at Organon & Co.
Market participants will track future SEC filings to see if leadership continues adding to their holdings. The next earnings report is scheduled for November 9, 2026, when the firm will update investors on its revenue and profit trajectory.
Related Filing Alerts
Source: Cynthia Patton's Form 4 filing on $OGN (Jun 12, 2026). Find the original filing: OGN Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts